Clinical Trial

Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the role of Somatropin and Dehydroepiandrosterone (DHEA) on ovarian reserve parameters and intracytoplasmic sperm injection (ICSI) outcome in poor ovarian responder. The main question it aims to answer is: Which intervention is more effective in increasing number and size of follicles? Participants will be followed 1 month before starting induction in growth hormone and 12 weeks for DHEA and through intracytoplasmic sperm injection (ICSI) cycle.
Trial Details
NCT Number NCT07323329
Lead Sponsor Beni-Suef University
Conditions Infertility, Infertility (IVF Patients)
Enrollment 165 participants
Start Date 2025-10-10
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-11-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-07